204 related articles for article (PubMed ID: 32433613)
1. Structure of nevanimibe-bound tetrameric human ACAT1.
Long T; Sun Y; Hassan A; Qi X; Li X
Nature; 2020 May; 581(7808):339-343. PubMed ID: 32433613
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for catalysis and substrate specificity of human ACAT1.
Qian H; Zhao X; Yan R; Yao X; Gao S; Sun X; Du X; Yang H; Wong CCL; Yan N
Nature; 2020 May; 581(7808):333-338. PubMed ID: 32433614
[TBL] [Abstract][Full Text] [Related]
3. Molecular structures of human ACAT2 disclose mechanism for selective inhibition.
Long T; Liu Y; Li X
Structure; 2021 Dec; 29(12):1410-1418.e4. PubMed ID: 34520735
[TBL] [Abstract][Full Text] [Related]
4. Acyl coenzyme A: cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis.
Rudel LL; Lee RG; Cockman TL
Curr Opin Lipidol; 2001 Apr; 12(2):121-7. PubMed ID: 11264983
[TBL] [Abstract][Full Text] [Related]
5. Purification of recombinant acyl-coenzyme A:cholesterol acyltransferase 1 (ACAT1) from H293 cells and binding studies between the enzyme and substrates using difference intrinsic fluorescence spectroscopy.
Chang CC; Miyazaki A; Dong R; Kheirollah A; Yu C; Geng Y; Higgs HN; Chang TY
Biochemistry; 2010 Nov; 49(46):9957-63. PubMed ID: 20964445
[TBL] [Abstract][Full Text] [Related]
6. Investigating the allosterism of acyl-CoA:cholesterol acyltransferase (ACAT) by using various sterols: in vitro and intact cell studies.
Liu J; Chang CC; Westover EJ; Covey DF; Chang TY
Biochem J; 2005 Oct; 391(Pt 2):389-97. PubMed ID: 15992359
[TBL] [Abstract][Full Text] [Related]
7. A critical role for the histidine residues in the catalytic function of acyl-CoA:cholesterol acyltransferase catalysis: evidence for catalytic difference between ACAT1 and ACAT2.
An S; Cho KH; Lee WS; Lee JO; Paik YK; Jeong TS
FEBS Lett; 2006 May; 580(11):2741-9. PubMed ID: 16647063
[TBL] [Abstract][Full Text] [Related]
8. Nanodisc scaffold peptide (NSP
Neumann B; Chao K; Chang CCY; Chang TY
Arch Biochem Biophys; 2020 Sep; 691():108518. PubMed ID: 32735863
[TBL] [Abstract][Full Text] [Related]
9. Structural insights into the inhibition mechanism of human sterol O-acyltransferase 1 by a competitive inhibitor.
Guan C; Niu Y; Chen SC; Kang Y; Wu JX; Nishi K; Chang CCY; Chang TY; Luo T; Chen L
Nat Commun; 2020 May; 11(1):2478. PubMed ID: 32424158
[TBL] [Abstract][Full Text] [Related]
10. Acute ACAT1/SOAT1 Blockade Increases MAM Cholesterol and Strengthens ER-Mitochondria Connectivity.
Harned TC; Stan RV; Cao Z; Chakrabarti R; Higgs HN; Chang CCY; Chang TY
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982602
[TBL] [Abstract][Full Text] [Related]
11. Roles of acyl-coenzyme A:cholesterol acyltransferase-1 and -2.
Chang TY; Chang CC; Lin S; Yu C; Li BL; Miyazaki A
Curr Opin Lipidol; 2001 Jun; 12(3):289-96. PubMed ID: 11353332
[TBL] [Abstract][Full Text] [Related]
12. Role of the N-terminal hydrophilic domain of acyl-coenzyme A:cholesterol acyltransferase 1 on the enzyme's quaternary structure and catalytic efficiency.
Yu C; Zhang Y; Lu X; Chen J; Chang CC; Chang TY
Biochemistry; 2002 Mar; 41(11):3762-9. PubMed ID: 11888294
[TBL] [Abstract][Full Text] [Related]
13. Blocking cholesterol storage to treat Alzheimer's disease.
Chang TY; Chang CCY; Harned TC; De La Torre AL; Lee J; Huynh TN; Gow JG
Explor Neuroprotective Ther; 2021 Dec; 1(3):173-184. PubMed ID: 35199105
[TBL] [Abstract][Full Text] [Related]
14. Triton X-100 or octyl glucoside inactivates acyl-CoA:cholesterol acyltransferase 1 by dissociating it from a two-fold dimer to a two-fold monomer.
Neumann B; Chang CCY; Chang TY
Arch Biochem Biophys; 2019 Aug; 671():103-110. PubMed ID: 31251920
[TBL] [Abstract][Full Text] [Related]
15. Compared with Acyl-CoA:cholesterol O-acyltransferase (ACAT) 1 and lecithin:cholesterol acyltransferase, ACAT2 displays the greatest capacity to differentiate cholesterol from sitosterol.
Temel RE; Gebre AK; Parks JS; Rudel LL
J Biol Chem; 2003 Nov; 278(48):47594-601. PubMed ID: 12975367
[TBL] [Abstract][Full Text] [Related]
16. Acyl-coenzyme A:cholesterol acyltransferases.
Chang TY; Li BL; Chang CC; Urano Y
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E1-9. PubMed ID: 19141679
[TBL] [Abstract][Full Text] [Related]
17. Potential role of acyl-coenzyme A:cholesterol transferase (ACAT) Inhibitors as hypolipidemic and antiatherosclerosis drugs.
Leon C; Hill JS; Wasan KM
Pharm Res; 2005 Oct; 22(10):1578-88. PubMed ID: 16180116
[TBL] [Abstract][Full Text] [Related]
18. ACAT1 deficiency increases cholesterol synthesis in mouse peritoneal macrophages.
Dove DE; Su YR; Swift LL; Linton MF; Fazio S
Atherosclerosis; 2006 Jun; 186(2):267-74. PubMed ID: 16144700
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of acyl-coenzyme A: cholesterol acyltransferase-1 and elevated cholesteryl esters in the hippocampus after excitotoxic injury.
Kim JH; Ee SM; Jittiwat J; Ong ES; Farooqui AA; Jenner AM; Ong WY
Neuroscience; 2011 Jun; 185():125-34. PubMed ID: 21514367
[TBL] [Abstract][Full Text] [Related]
20. Acyl-CoA:cholesterol acyltransferase 1 mediates liver fibrosis by regulating free cholesterol accumulation in hepatic stellate cells.
Tomita K; Teratani T; Suzuki T; Shimizu M; Sato H; Narimatsu K; Usui S; Furuhashi H; Kimura A; Nishiyama K; Maejima T; Okada Y; Kurihara C; Shimamura K; Ebinuma H; Saito H; Yokoyama H; Watanabe C; Komoto S; Nagao S; Sugiyama K; Aosasa S; Hatsuse K; Yamamoto J; Hibi T; Miura S; Hokari R; Kanai T
J Hepatol; 2014 Jul; 61(1):98-106. PubMed ID: 24657401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
